您的位置: 首页 > 农业专利 > 详情页

Treatment of pulmonary arterial hypertension with mesenchymal stem cells
专利权人:
UNITED THERAPEUTICS CORPORATION
发明人:
JEFFS, Roger,PETERSEN, Thomas,ILAGAN, Roger M.,WADE, Michael
申请号:
AU2018201231
公开号:
AU2018201231A1
申请日:
2018.02.21
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
#$%^&*AU2018201231A120180315.pdf#####ABSTRACT The application is directed to a method for treating or preventing vasculopathy comprising administrating to a subject in need thereof a pharmaceutical composition comprising mesenchymal precursor cells (MPCs) and a prostacyclin. Also provided a method for treating or preventing vasculopathy in a subject in need thereof, comprising administering to the subject a prostacyclin and a mesenchymal stem cell (MSC) or a MSC-conditioned culture medium or administering to the subject a MSC or a MSC-conditioned culture medium that has treated with prostacyclin. Pharmaceutical compositions suitable for such treatments are also provided. 9995647_1 (GHMatters) P99225.AU.1
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充